Life Sciences Liability Gaps Emerged With AI Adoption
Healthcare operators must re-evaluate product liability coverage as software becomes subject to strict EU regulations.
Updated on Oct. 5, 2026 in Healthcare
Live Poll
Do you trust that companies are held accountable when medical AI systems cause patient harm?
Zurich Insurance Group released a report, Beyond 2030: The Future of Life Sciences, highlighting how the integration of AI and complex data models into clinical care is outpacing existing risk management frameworks. New EU regulations will soon classify AI systems as products, triggering strict liability for manufacturers.
Why it matters
The shift creates significant financial exposure for businesses as traditional liability policies often exclude AI-related bodily injury. Rapid technological acceleration and increased reliance on cloud-based ecosystems mean clinical providers are increasingly vulnerable to systemic risks that fall outside standard coverage.
The study utilized insights from 34 industry experts and 62 specialists to assess risks within the life sciences sector. The data follows a 2024 clearinghouse breach that impacted 75% of American hospitals and 460 ransomware attacks recorded in the US healthcare sector throughout 2025.
The players
Zurich Insurance Group
A multinational insurance provider that underwrites complex commercial and professional liability risks for the life sciences sector.
The details
The upcoming EU Product Liability Directive, taking effect in December 2026, forces a change in how software and AI systems are treated, holding manufacturers liable for defects in these digital products. Because AI systems operate across drug, app, and device ecosystems, attributing liability for harm has become difficult. Businesses utilizing outcome-based contracts face prolonged financial and contractual obligations that often remain active for years following initial patient treatment.
Timeline
2024: A clearinghouse breach disrupted care at 75% of American hospitals.
December 2024: The EU revised Product Liability Directive entered force.
End of 2025: FDA registry reached 1,450 AI-enabled medical devices.
2025: The US healthcare sector recorded 460 ransomware attacks.
December 2026: The EU Product Liability Directive takes effect.
Market Landscape
The findings follow the evolution of the EU Product Liability Directive, which mandates new standards for digital product safety. This aligns with a broader trend where regulatory bodies are catching up to the rapid integration of AI and cloud dependencies in clinical settings.
Operators should review current professional and product liability policies to identify gaps regarding AI-driven outcomes or software failures. Prepare for the December 2026 EU compliance deadline by auditing all clinical software systems for potential liability exposure.
The takeaway
The intersection of high-cost gene therapy and AI-integrated clinical tools is creating a permanent shift in liability attribution. Ensure your legal counsel reviews all outcome-based contracts to confirm if liability coverage extends to automated diagnostic errors.
Further reading
For more on managing industry-specific risks, visit Healthcare.
Source note: This article includes information reported by Insurance Business.
Live Poll
Do you trust that companies are held accountable when medical AI systems cause patient harm?
